According to Lumos Pharma's latest financial reports the company's current EPS (TTM) is -HK$36.55. In 2022 the company made an earnings per share (EPS) of -HK$35.86 a decrease over its 2021 EPS that were of -HK$28.02.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$36.91 | 2.95% |
2022 | -HK$35.86 | 27.98% |
2021 | -HK$28.02 | 305.62% |
2020 | -HK$6.91 | -90.26% |
2019 | -HK$70.93 | -29.48% |
2018 | -HK$100.58 | -38.72% |
2017 | -HK$164.14 | -20.07% |
2016 | -HK$205.35 | 111.51% |
2015 | -HK$97.09 | -137.77% |
2014 | HK$257.04 | -396.77% |
2013 | -HK$86.61 | 10.71% |
2012 | -HK$78.23 | 6.4% |
2011 | -HK$73.52 |